Joint Formulary & PAD

Uridine triacetate - 5-Fluorouracil or capecitabine toxicity

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Granules
Associated Icons :
SPC
Restrictions / Comments :

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Uridine triacetate
Indication :
5-Fluorouracil or capecitabine toxicity
Group Name :
Keywords :
Brand Names Include :
Important Information :

https://www.toxbase.org/ . Stock not held by Surrey Trusts. Available from regional centres. Refer to TOXBASE / NPIS for advice

Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Committee Recommendations (1)

The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.

Other Indications

Below are listed other indications that Uridine triacetate is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat 5-Fluorouracil or capecitabine toxicity.

  • No records returned.